In Brief: Abbott Zyflo
Executive Summary
Abbott Zyflo: Supplemental NDA filed for labeling change to permit gradual reduction in dose frequency for Zyflo (zileuton) in asthma patients adequately controlled by current recommended dose of 600 mg four times daily. Abbott submits data from study using step-down approach to three-times-daily dosing followed by twice-daily dosing...